RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
SMYSX
Price
$24.19
Change
-$0.72 (-2.89%)
Updated
Dec 18 closing price
Ad is loading...

RWIBX vs SMYSX

Header iconRWIBX vs SMYSX Comparison
Open Charts RWIBX vs SMYSXBanner chart's image
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
Franklin Global Equity IS
Price$24.19
Change-$0.72 (-2.89%)
VolumeN/A
CapitalizationN/A
RWIBX vs SMYSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWIBX vs. SMYSX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIBX is a Buy and SMYSX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. SMYSX (404M). SMYSX pays higher dividends than RWIBX: SMYSX (1.21) vs RWIBX (1.05). RWIBX was incepted earlier than SMYSX: RWIBX (23 years) vs SMYSX (5 years). RWIBX is a more actively managed with annual turnover of: 27.00 vs. SMYSX (24.00). RWIBX has a lower initial minimum investment than SMYSX: RWIBX (250) vs SMYSX (1000000). SMYSX annual gain was more profitable for investors over the last year : 26.02 vs. RWIBX (11.34). SMYSX return over 5 years is better than : 65.93 vs. RWIBX (29.64).
RWIBXSMYSXRWIBX / SMYSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years5 years-
Gain YTD9.78124.76839%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets121B404M29,950%
Annual Yield % from dividends1.051.2187%
Returns for 1 year11.3426.0244%
Returns for 3 years8.4129.6928%
Returns for 5 years29.6465.9345%
Returns for 10 years44.22N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics